Xue-Mei Du
Overview
Explore the profile of Xue-Mei Du including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
45
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Che Y, Sun Q, Du X, Ban Y
Materials (Basel)
. 2025 Feb;
18(3).
PMID: 39942139
This study proposes a frequency-selective absorber (FSA) with dual passbands and wide-angle oblique incidence. The design consists of a circuit analog (CA) sheet and a dual-bandpass frequency selective surface (FSS)...
2.
Zhao J, Du X, Si W, Zhao X, Zhou Z
Histol Histopathol
. 2024 Feb;
39(9):1197-1208.
PMID: 38318760
Background: Inositol polyphosphate 4-phosphatase type II (INPP4B) has been identified as a tumor repressor in several human cancers while its role in endometrial cancer has not been investigated yet. Therefore,...
3.
Yang H, Wei X, Gong J, Du X, Feng H, Su C, et al.
Sci Rep
. 2023 Nov;
13(1):18882.
PMID: 37919345
The Myodural Bridge (MDB) is a physiological structure that is highly conserved in mammals and many of other tetrapods. It connects the suboccipital muscles to the cervical spinal dura mater...
4.
Su Y, Zhao X, Ma R, Fu Y, Yang Z, Wu H, et al.
Int J Hyperthermia
. 2023 Jun;
40(1):2223374.
PMID: 37348853
Objectives: To establish a Bayesian network (BN) model to predict the survival of patients with malignant peritoneal mesothelioma (MPM) treated with cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC). Methods:...
5.
Wu H, Yang Z, Su Y, Ma R, Du X, Gao Y, et al.
World J Surg Oncol
. 2022 Oct;
20(1):350.
PMID: 36280841
Background: Malignant peritoneal mesothelioma (MPM) is a rare malignant tumor with a high mortality rate and extremely poor prognosis. In-depth pathological analysis is essential to assess tumor biological behaviors and...
6.
Su Y, Yang Z, Li X, Yu Y, Du X, Li Y
Int J Hyperthermia
. 2022 Apr;
39(1):706-712.
PMID: 35485308
Objectives: To investigate independent factors for the efficacy and safety of cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of diffuse malignant peritoneal mesothelioma (DMPM). Methods: The...
7.
Sun P, Du X, Gao Y, Zhao H, Wang L, Zhang Y, et al.
Crit Rev Eukaryot Gene Expr
. 2021 Sep;
31(4):21-33.
PMID: 34587433
We aimed to explore the clinicopathologic and histologic characteristics, as well as the (differential) diagnosis of retroperitoneal malignant solitary fibrous tumors (RMSFTs) in this study. Nine cases of RMSFTs were...
8.
Du X, Wei Y, Gao Y, Li Z, Zhang J, Chang H, et al.
Medicine (Baltimore)
. 2021 Mar;
100(12):e25264.
PMID: 33761726
Rationale: Primary peritoneal epithelioid mesothelioma of clear cell type is an extremely rare entity composed of clear cytoplasm. It is challenging to diagnose because of the morphological resemblance to clear...
9.
Yang Z, Chen Z, Ji Z, Lin Y, Zhang J, Ma R, et al.
Exp Anim
. 2021 Jan;
70(2):225-235.
PMID: 33473097
Malignant peritoneal mesothelioma (MPM) is a rare malignancy with few experimental models. This study used the human surgical specimen to establish MPM patient-derived xenograft (PDX) models and primary cell lines...
10.
Yang Z, Chen Z, Du X, Li Y
Front Oncol
. 2020 Dec;
10:585079.
PMID: 33365269
Objective: Malignant peritoneal mesothelioma (MPM) is a rare malignancy with few effective molecular therapies. In this study, we evaluated the anti-tumor activity and safety of apatinib, a vascular endothelial growth...